Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BILIBILI-W
09626
5
BABA-W
09988
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -7,117.43%-509.96K | -130.97%-1.75M | -6,802.51%-876.09K | -2,002.27%-481.52K | -132.95%-400.14K | 101.16%7.27K | 86.11%-757.9K | 100.57%13.07K | 101.75%25.31K | 75.81%-171.77K |
| Net income from continuing operations | -576.24%-2.49M | -64.00%-5.61M | -601.87%-4.74M | 79.34%-155.7K | 44.65%-342.44K | 73.13%-368.24K | 73.31%-3.42M | 56.14%-675.2K | 91.84%-753.51K | 30.46%-618.68K |
| Operating gains losses | ---- | --502.88K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -54.99%40.67K | -30.72%257.11K | -57.53%38.1K | -53.00%42.18K | -6.33%86.46K | -9.06%90.37K | 9.16%371.12K | -8.19%89.7K | 5.72%89.75K | 9.64%92.31K |
| Asset impairment expenditure | ---- | --78.45K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | --1.97M | --3.29M | --3.29M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cashItems | ---- | --69K | --80.15K | --0 | ---- | ---- | ---- | ---- | -100.00%-134 | --0 |
| Change In working capital | -110.52%-30K | -114.75%-337.62K | -120.35%-121.74K | -153.40%-368K | -137.51%-133.02K | -55.92%285.14K | 324.27%2.29M | 179.06%598.3K | 302.79%689.2K | 721.76%354.6K |
| -Change in receivables | 96.36%-743 | -105.14%-19.88K | -83.19%45.91K | -247.69%-48.16K | -76.78%2.79K | -129.53%-20.42K | 293.48%386.95K | 278.30%273.16K | 154.40%32.61K | 51.76%12.03K |
| -Change in prepaid assets | 14,745.02%85.23K | -110.24%-105.68K | -1,848.19%-113.95K | 32.99%-8.97K | -95.65%17.82K | -100.09%-582 | 198.94%1.03M | 100.89%6.52K | 95.50%-13.38K | 1,206.98%409.46K |
| -Change in payables and accrued expense | -134.42%-115.72K | -105.65%-63.25K | -102.42%-12.69K | -141.36%-279.88K | -274.19%-106.85K | 719.28%336.17K | 796.30%1.12M | 318.72%525.15K | 3,162.78%676.64K | -135.04%-28.56K |
| -Change in other working capital | 104.09%1.23K | 40.26%-148.82K | 80.14%-41.02K | -365.59%-30.99K | -22.02%-46.78K | -1,345.71%-30.03K | -164.99%-249.11K | -155.76%-206.53K | -95.42%-6.66K | -312.74%-38.34K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -7,117.43%-509.96K | -130.97%-1.75M | -6,802.51%-876.09K | -2,002.27%-481.52K | -132.95%-400.14K | 101.16%7.27K | 86.11%-757.9K | 100.57%13.07K | 101.76%25.31K | 75.88%-171.77K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -95.62K | -104.73K | -104.73K | 0 | 0 | 0 | ||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net intangibles purchas and sale | ---95.62K | ---104.73K | ---104.73K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---95.62K | ---104.73K | ---104.73K | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 43,593.43%927.28K | 403.29%2.55M | 6,209.62%918.11K | 2,662.89%602.75K | 3,589.82%1.03M | -100.48%-2.13K | -85.83%505.7K | -78.83%14.55K | -98.60%21.82K | -95.32%27.82K |
| Net issuance payments of debt | -1,006.47%-23.59K | -169.13%-349.59K | -1,230.32%-164.47K | -653.00%-120.64K | -324.13%-62.35K | -100.48%-2.13K | -26.46%505.7K | 146.13%14.55K | 238.96%21.82K | -95.70%27.82K |
| Net common stock issuance | --750K | --1.08M | ---731.98K | --723.4K | --1.09M | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | --200.87K | --1.81M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | --25.5K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 43,593.43%927.28K | 403.29%2.55M | 6,209.62%918.11K | 2,662.89%602.75K | 3,589.82%1.03M | -100.48%-2.13K | -85.83%505.7K | -78.83%14.55K | -98.60%21.82K | -95.32%27.82K |
| Net cash flow | ||||||||||
| Beginning cash position | 2,469.50%652.65K | -92.65%25.4K | 6,787.67%720.52K | 1,597.75%537.41K | -87.86%19.28K | -92.65%25.4K | 102.04%345.46K | -99.62%10.46K | -85.07%31.65K | -67.28%158.84K |
| Current changes in cash | 6,164.89%321.7K | 373.57%689.93K | -326.99%-62.7K | 157.23%121.23K | 535.04%626.26K | 102.81%5.14K | -218.94%-252.19K | 101.17%27.62K | -98.11%47.13K | 35.21%-143.96K |
| Effect of exchange rate changes | -97.02%-22.17K | 7.66%-62.67K | 59.25%-5.17K | 190.57%61.88K | -744.80%-108.13K | -209.60%-11.25K | -80.76%-67.87K | 80.07%-12.68K | -212.31%-68.32K | 132.66%16.77K |
| End cash Position | 4,838.44%952.18K | 2,469.50%652.65K | 2,469.50%652.65K | 6,787.67%720.52K | 1,597.75%537.41K | -87.86%19.28K | -92.65%25.4K | -92.65%25.4K | -99.62%10.46K | -85.07%31.65K |
| Free cash from | -8,433.26%-605.58K | -144.78%-1.86M | -7,603.73%-980.81K | -2,002.27%-481.52K | -132.95%-400.14K | 101.16%7.27K | 86.89%-757.9K | 100.57%13.07K | 101.57%25.31K | 78.96%-171.77K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.